IVIG(n=20) | Placebo(n=21) | Between | |||||
---|---|---|---|---|---|---|---|
SF-36 score | Before | 1 year | p | Before | 1 year | p | group diff. p |
mean (SD) | mean (SD) | mean (SD) | mean (SD) | ||||
PF | 33.2 (17.9) | 39.8 (19.2) | 0.014 | 40.7 (22.7) | 41.0 (22.0) | 0.761 | 0.028 |
RP | 30.0 (28.8) | 42.5 (39.8) | 0.240 | 50.0 (40.3) | 48.0 (40.0) | 0.757 | 0.278 |
BP | 50.8 (18.1) | 55.5 (21.6) | 0.189 | 55.4 (24.5) | 50.7 (27.3) | 0.224 | 0.075 |
GH | 53.1 (22.4) | 61.3 (24.2) | 0.058 | 58.1 (22.5) | 61.8 (24.2) | 0.190 | 0.290 |
VT | 43.0 (22.6) | 49.3 (27.3) | 0.267 | 46.4 (23.8) | 47.3 (22.2) | 0.948 | 0.300 |
SF | 66.9 (24.1) | 73.8 (26.6) | 0.094 | 70.8 (26.3) | 71.4 (23.8) | 0.897 | 0.191 |
RE | 61.7 (43.6) | 66.7 (40.5) | 0.665 | 63.5 (43.3) | 73.0 (38.9) | 0.261 | 0.736 |
MH | 74.4 (17.9) | 76.0 (19.3) | 0.652 | 72.6 (17.2) | 72.5 (17.6) | 0.881 | 0.844 |
PCS | 28.9 (6.1) | 32.8 (8.2) | 0.021 | 34.0 (10.0) | 33.1 (11.3) | 0.394 | 0.020 |
MCS | 48.7 (13.2) | 50.0 (12.5) | 0.681 | 47.6 (12.4) | 49.3 (11.9) | 0.192 | 0.531 |
VAS | 31(24) | 23(20) | 0.013 | 31(22) | 29(28) | 0.509 | 0.449 |
6MWT, m | 351 (110) | 400 (112) | <0.001 | 306 (111) | 325 (125) | 0.145 | 0.415 |
n=19 | n=19 | n=20 | n=20 |